Our mission

Making compliance review faster, sharper, and more consistent across UK pharma

The pharmaceutical industry operates under some of the most rigorous regulatory standards in the world — and rightly so. The ABPI Code of Practice exists to ensure that medicines are promoted responsibly, that healthcare professionals receive accurate information, and that patients are protected.

But the process of getting materials through medical, legal, and regulatory review is slow, inconsistent, and catches problems too late. Brand teams submit materials that aren't ready. Reviewers spend time on issues that could have been identified before the material ever reached them. Cycles stretch to weeks. Budgets slip. Launch timelines move.

PrimusReview was built to solve the first part of that problem. Not to replace the judgement of qualified medical, legal, and regulatory reviewers — but to give brand teams, medical writers, and agencies an intelligent first-pass check before formal review begins. Catch the obvious issues early. Submit better materials. Spend MLR time on the decisions that actually require human expertise.

What we believe

AI should augment compliance review, not replace it

Every output from PrimusReview is a first-pass analysis, not a regulatory opinion. Our platform is explicit about this — results must always be reviewed and validated by a qualified person before any material is submitted or used.

The ABPI Code is non-negotiable

We built PrimusReview specifically for the UK pharmaceutical regulatory environment. The 2024 ABPI Code is embedded into every review, updated with each new edition, and applied with the rigour the industry demands.

Compliance and speed are not opposites

Getting to market faster doesn't mean cutting corners. It means identifying and fixing issues earlier in the process, so that by the time a material reaches formal MLR review, it's ready.

Trust is built through transparency

We are transparent about what PrimusReview can and cannot do. We document our data practices, our AI governance, and our security controls. Pharma companies operate in a high-trust environment and we hold ourselves to the same standard.

The founder
DT

Daniel Thompson

Founder, PrimusReview

Daniel has five years of experience across the UK pharmaceutical industry, working in regulatory affairs, NHS market access, brand management, and business intelligence. He has worked across pre-launch, launch, and post-launch phases, as well as established portfolio lifecycle management — giving him a firsthand understanding of the pressures that MLR teams and brand managers face at every stage of a product's commercial life.

PrimusReview was built from that experience — from having sat on both sides of the compliance process and recognising that the tools available to the industry hadn't kept pace with what AI now makes possible.

Ready to see it in action?

5 free reviews included. No credit card required. See what PrimusReview finds in your materials.

Start free trial →Get in touch